Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03802604
Title Combination of Talimogene Laherparepvec With Atezolizumab in Early Breast Cancer (PROMETEO)
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors SOLTI Breast Cancer Research Group
Indications

triple-receptor negative breast cancer

breast adenocarcinoma

Therapies

Atezolizumab + Talimogene laherparepvec

Age Groups: senior | adult
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Universitari Vall d'Hebrón Barcelona 08035 Spain Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Centro Integral Oncológico Clara Campal Madrid 28050 Spain Details
Hospital Clínico universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field